A fluvastatin hatása a szérum lipid szintekre esszenciális hipertóniás betegekben.

Translated title of the contribution: Effect of fluvastatin on serum lipid levels in essential hypertension

Z. Járai, J. Kapocsi, C. Farsang, K. Detki, G. Pados, Z. Sebestyén, J. Holló

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The efficacy and safety of the HMG-CoA reductase fluvastatin was investigated in a multicenter, open label clinical therapeutic trial in the treatment of hypercholesterinaemia in hypertensive patients (WHO I-II.). 49 patients were involved, 6 patients were dropped out because of th lack of compliance, 43 patients were investigated (mean age: 57.6 +/- 9.4 years, mean blood pressure: 146 +/- 16/88+/- g mmHg (systolic/diastolic). The antihypertensive treatment was unchanged during the study. An 8 weeks low-lipid diet was started if the fasting total cholesterol (TC) level was equal or higher than 6.5 mM/L and the triglyceride level was lower than 4.6 mM/L. After the dietary period fluvastatin treatment was started (20 mg o.d.), if the level of LDL-C was higher than 4,1 mM/L. Blood pressure, heart rate, TC, HDL-C (HDL2-C, HDL3-C), apoA1, apoB, TG were measured at the 4th, 8th, 12th weeks of treatment. LDL-C was calculated with Fridewald equation. The daily dose of fluvastatin was increased to 40 mg, if LDL-C level was higher than 3.5 mM/L after 4 weeks of treatment. 36 patients completed the study (Group B). 7 patients were dropped out at the end of the dietary period, because of the significant decrease of TC and LDL-C levels (Group A). In Group B fluvastatin significantly reduced the level of TC (from 7.22 +/- 0.88 to 5.99 +/- 0.98 mM/L), of LDL-C (from 5.13 +/- 0.71 to 3.95 +/- 0.88 mM/L), and the level of ApoB (from 0.97 +/- 0.26 to 0.85 +/- 0.15 mM/L), but did not influence significantly the level of HDL-C, ApoA1 and TG. The diastolic blood pressure decreased significantly during the dietary period, while after beginning the fluvastatin treatment the decrease of the systolic blood pressure became significant. There was no change in the heart rate. Only minor side effects were observed in 3 patients (dysuria, constipation, lack of appetite). Fluvastatin proved to be an effective and well-tolerated drug in the treatment of hypercholesterinaemia in hypertensive patients.

Translated title of the contributionEffect of fluvastatin on serum lipid levels in essential hypertension
Original languageHungarian
Pages (from-to)1857-1859
Number of pages3
JournalOrvosi hetilap
Volume137
Issue number34
Publication statusPublished - Aug 25 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effect of fluvastatin on serum lipid levels in essential hypertension'. Together they form a unique fingerprint.

  • Cite this

    Járai, Z., Kapocsi, J., Farsang, C., Detki, K., Pados, G., Sebestyén, Z., & Holló, J. (1996). A fluvastatin hatása a szérum lipid szintekre esszenciális hipertóniás betegekben. Orvosi hetilap, 137(34), 1857-1859.